IV Therapy Flash Cards
IV Therapy Flash Cards
IV Therapy Flash Cards
Copyright © 2009 by F. A. Davis Company. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored
in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written
permission from the publisher.
Printed in Mexico
Last digit indicates print number: 10 9 8 7 6 5 4 3 2 1
As new scientific information becomes available through basic and clinical research, recommended treatments and drug therapies undergo changes.
The author(s) and publisher have done everything possible to make this book accurate, up to date, and in accord with accepted standards at the time
of publication. The author(s), editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and
make no warranty, expressed or implied, in regard to the contents of the book. Any practice described in this book should be applied by the reader
in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised
always to check product information (package inserts) for changes and new information regarding dose and contraindications before administering
any drug. Caution is especially urged when using new or infrequently ordered drugs.
ISBN3: 978-0-8036-2141-1
ISBN 10: 0-8036-2141-8
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by F. A. Davis Company for
users registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided that the fee of $.25 per copy is paid directly
to CCC, 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license by CCC, a separate system
of payment has been arranged. The fee code for users of the Transactional Reporting Service is: 8036-2141-8/09 0 ⫹ $.25.
Table of Contents:
Section 1: Infection Control Related to IV Therapy 1–27
Section 2: Fluid, Electrolytes, and Parenteral Solutions 28–55
Section 3: Equipment 56–78
Section 4: Technique/Maintenance Peripheral IVs 79–100
Section 5: Technique/Maintenance Central IVs 101–113
Section 6: Complications 114–136
Section 7: Infusion Modalities 137–146
Section 8: Transfusion Therapy 147–160
Section 9: Nutritional Support 161–165
Section 10: IV Therapy Bonus Cards, Illustration Credits 166–170
Guide to Pronunciation:
Pronunciations are spelled phonetically; pronunciations, diacritical marks (long and short vowels), and
stressses on syllables ( ' for primary and '' for secondary) follow Taber’s Cyclopedic Medical Dictionary.
See “Features and Their Use” in the dictionary for more information.
Dedication
To my mother, Margie Schuetz, thank you for your unconditional love.
Acknowledgments
Christina C. Burns, Project Editor
Thomas A. Ciavarella, Acquisitions Editor
Infusion Nurses Society
Reviewers
Michelle Crum, RN, BSN Shirley Lyon Garcia, RN, BSN
Nursing Instructor Adjunct Faculty, PNE Instructor
Ozarks Technical Community College McDowell Technical Community College
Springfield, Missouri Marion, North Carolina
Debra J. Dichiara, MSN, RN Mary M. Goetteman, RN, EdD
Associate Professor Professor
Daytona Beach College Daytona Beach College
Daytona Beach, Florida Daytona Beach, Florida
Gay Oyco Divinagracia, MA, RN, BC Sung Gwak, MSN, CCRN, BC, RN
Associate Professor Associate Professor
Indian River Community College Borough of Manhattan Community College
Fort Pierce, Florida New York, New York
Roxanne Hurley, MS, RN Karen Reilly, MSN, ARNP
Clinical Associate Professor Associate Professor
University of North Dakota Daytona Beach College
Grand Forks, North Dakota Daytona Beach, Florida
Mark R. Kucharek, RN, MSN Kay Schwartzwelder, MSN, RN
Assistant Director of Nursing Associate Director of Nursing and Allied Health
Mohave Community College Collins Career Center
Kingman, Arizona Chesapeake, Ohio
Instructor
Cynthia Levering, RN, Med, MS, CNS
Ohio University
Associate Professor
Ironton, Ohio
Central Ohio Technical College
Newark, Ohio Jill Scott, RN, MSN, CCRN
Nursing Professor
Missy Mohler, MS, RN
St. Johns River Community College
Nursing Instructor
Palatka, Florida
Hocking College
Nelsonville, Ohio
Barbara Tacinelli, RN, MA Judith Valloze, ARNP, MSN
Professor of Nursing Professor of Nursing
Borough of Manhattan Community College Daytona Beach College
New York, New York Daytona Beach, Florida
Mary Tan, PhD, RN
Assistant Director Susan Waltz, RN, DNP
Holmes Community College Nursing Department Chair
Ridgeland, Mississippi Ivy Tech Community College of Indiana,
Columbus Campus
Diana C. Tilton, RN, BSN, CRNI®
Columbus, Indiana
Assistant Professor
Johnson Community College
Overland Park, Kansas
Getting the Most Out of Your IV Therapy Flash Cards
Purpose of Flash Cards
You’re on your way to mastering IV therapy vocabulary! Using these flash cards will develop
your ability to focus and achieve deep memory learning. They will help you not only learn
the terminology, but they will help you relate those terms to the nursing content you are
studying. It is important to make a connection between the term, its meaning, and how it
functions in the language of nursing. So I designed the flash cards to allow you to see the
word, read the word (out loud is best), use the word, and associate the word with other
related concepts.
How to Use Flash Cards
This set of flash cards is unique because it gives you opportunities to actively associate each
word or phrase with your studies. Here are some strategies I recommend to get the most out
of the time you spend with the cards. But these are not the only ways they can be used; see
if you can think of others that better suit your learning style.
1. Write the word on a separate piece of paper and recite the word out loud.
2. Work with a partner, take turns saying words out loud to each other, and recite their defi-
nitions. Check your achievement by turning over the cards to see if you provided the
correct definitions.
3. Draw a picture of the word on a separate piece of paper if you are having trouble remem-
bering it. This is called concept mapping—an example is on the back of this card.
4. On the back of each card is a “notes” area that you can use to include associated
concepts from a textbook or lecture. Example:
✓Notes: Phlebitis ⫽ occurs frequently from mechanical or chemical irritation to the vein.
Must anchor IV securely
5. To review for a test, mix up the sections, and use these same strategies as above to test
your understanding of all the words and concepts.
DavisPlus Web Site: On the DavisPlus Web site , you will find additional terms and
definitions. Visit http://davisplus.fadavis.com to access this content.
Concept Mapping
Concept mapping is a thinking tool that reflects externally what is going on in your brain.
Each map is unique to the student creating the map. The steps are simple and can be
used for any nursing content.
1. Write the word on a blank piece of paper.
2. Create stems off the word using different colors, and curve the stems leading from the
central word.
Note: The brain connects better with free flowing curves rather than straight lines.
3. Write words on the stems that connect ideas to the center word. (Narrow-tip colored
marking pens work great.)
4. Write one word on each stem and make the stem the length of the word.
5. Draw smaller branches coming off each large stem, again the length of the word you
are going to write, and only one word per branch.
6. Draw pictures if you wish, adding them next to the appropriate stem. Search for images
online or create your own drawings. The brain connects to the word or term through
pictures.
Lynn Phillips
Concept Mapping Sample
1. INFECTION CONTROL
aerobic
(ĕr-ō'bı̆k)
1. INFECTION CONTROL
APPLICATION: NOTES:
The physician ordered an aero- ____________________________________________
bic culture of the wound. ____________________________________________
____________________________________________
____________________________________________
2. INFECTION CONTROL
airborne precautions
(ār'born prē-kŏ'shĕnz)
2. INFECTION CONTROL
anaerobic
(ăn'' ĕr-ō'bı̆k)
3. INFECTION CONTROL
APPLICATION: NOTES:
The nurse collected the wound ____________________________________________
sample from deep in a tunneled ____________________________________________
portion of the wound for an
anaerobic culture. ____________________________________________
____________________________________________
4. INFECTION CONTROL
antibodies
(ăn'tı̆-bŏd''ēz)
4. INFECTION CONTROL
APPLICATION: NOTES:
Antibodies are proteins that ____________________________________________
target antigens and destroy them ____________________________________________
using the following four methods:
phagocytosis, neutralization, ____________________________________________
agglutination, and activation of ____________________________________________
complement and inflammation.
5. INFECTION CONTROL
antigen
(ăn'tı̆-jĕn)
5. INFECTION CONTROL
APPLICATION: NOTES:
The combination of an antigen ____________________________________________
with its specific antibody is ____________________________________________
called antigen-antibody reaction.
____________________________________________
____________________________________________
6. INFECTION CONTROL
bacteristatic
(băk-tēr''ē-stăt'ı̆k)
6. INFECTION CONTROL
APPLICATION: NOTES:
The cephalosporin anti-infectives ____________________________________________
are considered bacteristatic. ____________________________________________
____________________________________________
____________________________________________
7. INFECTION CONTROL
bactericidal
(băk''tĕr-ı̆-sı̄'dăl)
7. INFECTION CONTROL
APPLICATION: NOTES:
Penicillin is considered an ____________________________________________
anti-infective that is bactericidal. ____________________________________________
____________________________________________
____________________________________________
8. INFECTION CONTROL
APPLICATION: NOTES:
Standard precautions are used ____________________________________________
for all hospitalized patients to ____________________________________________
prevent the spread of blood borne
pathogens. ____________________________________________
____________________________________________
9. INFECTION CONTROL
APPLICATION: NOTES:
Bloodstream infections related to ____________________________________________
placement of a central venous ____________________________________________
access device (CVAD) in the
early stages are caused by bacte- ____________________________________________
rial contamination during the ____________________________________________
initial catheter insertion.
10. INFECTION CONTROL
APPLICATION: NOTES:
In 2002, the Centers for Disease ____________________________________________
Control and Prevention pub- ____________________________________________
lished guidelines for prevention
of intravascular catheter-related ____________________________________________
infections. ____________________________________________
11. INFECTION CONTROL
chain of infection
(chān of ı̆n-fĕk'shŭn)
11. INFECTION CONTROL
APPLICATION: NOTES:
Health-care workers must either ____________________________________________
clean their hands with an ____________________________________________
alcohol-based solution or wash
with soap and water frequently to ____________________________________________
assist in breaking the chain of ____________________________________________
infection.
12. INFECTION CONTROL
colonization
(kŏl''ŏ-nı̆-zā'shŭn)
12. INFECTION CONTROL
APPLICATION: NOTES:
The culture taken from the ____________________________________________
nurse’s fingernails showed colo- ____________________________________________
nization of Staphylococcus
aureus. ____________________________________________
____________________________________________
13. INFECTION CONTROL
contact precautions
(kŏn'tăkt'' prē-kŏ'shĕnz)
13. INFECTION CONTROL
APPLICATION: NOTES:
The patient with a diagnosis of ____________________________________________
Clostridium difficile (C. difficile) ____________________________________________
was placed on contact precautions.
____________________________________________
____________________________________________
14. INFECTION CONTROL
droplet precautions
(drŏp'lĕt prē-kŏ'shĕnz)
14. INFECTION CONTROL
APPLICATION: NOTES:
Droplet precautions include the use ____________________________________________
of a mask and eye protection when ____________________________________________
working within 3 ft of a patient, in
addition to standard and contact ____________________________________________
precaution guidelines. ____________________________________________
15. INFECTION CONTROL
dissemination
(dı̆-sĕm'ı̆-nā''shŭn)
15. INFECTION CONTROL
APPLICATION: NOTES:
The outpatient clinic, with its ____________________________________________
recent outbreak of staphylococ- ____________________________________________
cus, cultured all asymptomatic
staff for dissemination of the ____________________________________________
organism. ____________________________________________
16. INFECTION CONTROL
endogenous
(ĕn-dŏj'ĕ-nŭs)
16. INFECTION CONTROL
APPLICATION: NOTES:
The most common endogenous ____________________________________________
organism is Staphylococcus ____________________________________________
aureus.
____________________________________________
____________________________________________
17. INFECTION CONTROL
exogenous
(ĕks-ŏj'ĕ-nŭs)
17. INFECTION CONTROL
APPLICATION: NOTES:
The patient acquired a nosoco- ____________________________________________
mial infection from an exogenous ____________________________________________
source, the intensive care nurse’s
hands. ____________________________________________
____________________________________________
18. INFECTION CONTROL
1. extrinsic contamination
(ĕks-trı̆n'sı̆k kŏn-tăm''ı̆-nā'shŭn)
2. intrinsic contamination
(ı̆n-trı̆n'zı̆k kŏn-tăm''ı̆-nā'shŭn)
18. INFECTION CONTROL
APPLICATION: NOTES:
The IV therapy–related BSI was ____________________________________________
traced to extrinsic contamination ____________________________________________
from improperly administered IV
solution. ____________________________________________
____________________________________________
19. INFECTION CONTROL
hand hygiene
(hănd hı̄'jēn)
19. INFECTION CONTROL
APPLICATION: NOTES:
The transmission of healthcare- ____________________________________________
associated pathogens from one ____________________________________________
patient to another via the hands of
health-care workers requires a ____________________________________________
sequence of events. Hand hygiene ____________________________________________
breaks the sequence of events.
20. INFECTION CONTROL
healthcare-associated
infections (HAIs)
(hĕlth'kār ă'sō-sē-ā''tĕd ı̆n-f ĕk'shŭnz)
20. INFECTION CONTROL
APPLICATION: NOTES:
In hospitals alone, healthcare- ____________________________________________
associated infections (HAIs) ____________________________________________
account for an estimated 2 million
infections, 90,000 deaths, and ____________________________________________
$4.5 billion in excess health-care ____________________________________________
costs annually (CDC, 2006.)
21. INFECTION CONTROL
host
(hōst)
21. INFECTION CONTROL
APPLICATION: NOTES:
The frail, 90-year-old man had ____________________________________________
impaired defenses due to pneu- ____________________________________________
monia and, therefore, was a com-
promised host. ____________________________________________
____________________________________________
22. INFECTION CONTROL
immunosuppression
(ı̆m''ū-nō-sū-prĕsh'ŭn)
22. INFECTION CONTROL
APPLICATION: NOTES:
Immunosuppression can occur in ____________________________________________
patients receiving chemotherapy. ____________________________________________
____________________________________________
____________________________________________
23. INFECTION CONTROL
leukopenia
(loo''kō-pē'nē-ă)
23. INFECTION CONTROL
APPLICATION: NOTES:
The immunocompromised ____________________________________________
patient was admitted with ____________________________________________
leucopenia and placed on
neutropenic precautions. ____________________________________________
____________________________________________
24. INFECTION CONTROL
reservoir
(rĕz'ĕr-vwor)
24. INFECTION CONTROL
APPLICATION: NOTES:
The patient with a staphylococ- ____________________________________________
cus infection in the wound was ____________________________________________
the reservoir for transmission by
wound drainage. ____________________________________________
____________________________________________
25. INFECTION CONTROL
susceptible host
(sŭ-sĕp'tı̆-bl hōst)
25. INFECTION CONTROL
APPLICATION: NOTES:
The client with AIDS is a suscep- ____________________________________________
tible host for opportunistic infec- ____________________________________________
tious organisms.
____________________________________________
____________________________________________
26. INFECTION CONTROL
transient flora
(trăns'zē-ĕnt flŏr'ă)
26. INFECTION CONTROL
APPLICATION: NOTES:
The nurse used a 15-second, ____________________________________________
vigorous scrub to remove transient ____________________________________________
skin flora prior to insertion of an
intravascular device. ____________________________________________
____________________________________________
27. INFECTION CONTROL
virulence
(vı̆r' ū-lĕns)
27. INFECTION CONTROL
APPLICATION: NOTES:
The microorganism’s ability to ____________________________________________
produce disease includes viru- ____________________________________________
lence, dose (number of organisms
available to infect), susceptible ____________________________________________
host, and dissemination. ____________________________________________
28. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. acidosis
(ăs''ı̆-dō'sı̆s)
2. alkalosis
(ăl''kă-lō'sı̆s)
28. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
DE
AT
or an excessive loss of
AT
DE
H
bicarbonate. The hydro-
gen ion concentration of
1 part of carbonic acid 20 parts of biocarbonate
the fluid is increased, H2CO3 1.20 mM/L HCO3- 24 mEq/L
lowering the pH. A pH
less than 7.35.
APPLICATION:
2. An actual or relative
The body maintains the plasma pH within the narrow normal range of
increase in blood alka-
7.35 to 7.45. It does so by means of chemical buffering mechanisms
linity due to an accu- utilized by the kidneys and by the lungs to prevent acidosis or
mulation of alkalies or alkalosis.
reduction of acids. A
pH above 7.45.
29. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
active transport
(ăk'tı̆v trăns''pŏrt)
29. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The sodium-potassium pump, which is located in the cell membrane, ____________________
in the presence of adenosine triphosphate (ATP) actively moves sodium ____________________
from inside the cell into the extracellular fluid (ECF) by active
transport. ____________________
____________________
30. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. anion
(ăn'ı̄-ŏn)
2. cation
(kăt'ı̄-ŏn)
30. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The unit of measure for anions ____________________________________________
and cations is milliequivalents ____________________________________________
per liter (mEq/L).
____________________________________________
____________________________________________
31. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
Chvostek’s sign
(vōs'tĕks sı̄n)
31. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The patient postoperative for ____________________________________________
thyroidectomy began to have ____________________________________________
signs of hypocalcemia including
numbness of the fingers, cramps ____________________________________________
in the muscles of the legs, and ____________________________________________
positive Chvostek’s sign.
32. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
colloid
(kŏl'oyd)
32. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
Albumin 25% (a colloid solu- ____________________________________________
tion) was ordered to maintain ____________________________________________
blood volume for the 24-year-old
male, auto accident victim prior ____________________________________________
to administration of packed ____________________________________________
cells.
33. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
crystalloid
(krı̆'stăl-oyd'')
33. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
Many crystalloid solutions ____________________________________________
contain dextrose as the carbohy- ____________________________________________
drate, calorie source.
____________________________________________
____________________________________________
34. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The patient admitted to the ED ____________________________________________
after a gunshot wound to the ____________________________________________
right shoulder, had extracellular
fluid volume deficit due to the ____________________________________________
blood loss. ____________________________________________
35. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
hydrating solution
(hı̄'dr āt-ı̆ng sō-lū'shŭn)
36. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The client was admitted to the emergency department for intractable ____________________
vomiting and 3 days of diarrhea. An IV was started with a 5% dextrose ____________________
in 0.45% sodium chloride, a hydrating solution, to determine kidney
status and begin hydration before replacement of potassium chloride. ____________________
____________________
37. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. hypotonic
(hı̄''pō-tŏn'ı̆k)
2. hypertonic
(hı̄''p ĕr-tŏn'ı̆k)
3. isotonic
(ı̄''sō-tŏn'ı̆k)
37. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. hypercalcemia
(hı̄''pĕr-kăl-sē'mē-ă)
2. hypocalcemia
(hı̄''pō-kăl-sē'mē-ă)
38. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. hyperkalemia
(hı̄''pĕr-kă-lē'mē-ă)
2. hypokalemia
(hı̄''pō-kă-lē'mē-ă)
39. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
Patients receiving diuretics must have laboratory potassium values ____________________
evaluated periodically for hypokalemia due to loss of potassium in the ____________________
urine.
____________________
____________________
40. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. hypermagnesemia
(hı̄''pĕr-măg''nĕ-sē'mē-ă)
2. hypomagnesemia
(hı̄''pō-măg''n ĕ-sē'mē-ă)
40. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The preeclampsia patient in labor and delivery receiving magnesium ____________________
sulfate must be monitored for hypermagnesemia including fetal heart ____________________
tones.
____________________
____________________
41. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. hypernatremia
(hı̄''pĕr-nă-trē'mē-ă)
2. hyponatremia
(hı̄''pō-nă-trē'mē-ă)
41. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
Hyponatremia is the most frequent electrolyte disorder seen in clinical ____________________
practice. ____________________
____________________
____________________
42. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. hypervolemia
(hı̄''pĕr-vō-lē'mē-ă)
2. hypovolemia
(hı̄''pō-vō-lē'mē-ă)
42. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
Nurses can help to prevent hypovolemia or hypervolemia by identifying ____________________
patients who have the highest risk for developing either fluid volume
____________________
deficit (older adults, infants and children), and conditions associated
with fluid loss (e.g., vomiting, fever); or fluid volume excess by moni- ____________________
toring intake and output and observing patients for signs and symp- ____________________
toms of fluid overload.
43. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
ions
(ı̄'ŏnz)
43. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The unit of measurement for ions is usually milliequivalents per liter ____________________
(mEq/L), or can be expressed as millimoles per liter (mmol/L) as is ____________________
chemical activity of the electrolytes. Milligrams per 100 mL express
the weight of the solute per unit volume. ____________________
____________________
44. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
interstitial fluid
(ı̆n''tĕr-stı̆sh'ăl floo'ı̆d)
44. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The extracellular fluid is divided ____________________________________________
into plasma space, approxi- ____________________________________________
mately 5% of total body weight,
and interstitial fluid approxi- ____________________________________________
mately 15% of body weight. ____________________________________________
45. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
Intracellular fluid accounts for ____________________________________________
approximately 40% of total body ____________________________________________
weight.
____________________________________________
____________________________________________
46. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
maintenance solution
(mān'tĕ-nănts sō-lū'shŭn)
46. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The patient, NPO for laparo- ____________________________________________
scopic cholecystectomy, received ____________________________________________
intravenous maintenance solu-
tions until discharge from the ____________________________________________
outpatient surgery center. ____________________________________________
47. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. metabolic acidosis
(mĕt''ă-bŏl'ı̆k ăs''ı̆-dō'sı̆s)
2. metabolic alkalosis
(mĕt''ă-bŏl'ı̆k ăl''kă-lō'sı̆s)
47. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION:
A patient presented to the ED with vomiting for the past three days. His blood gases were pH- 7.56, PaCO2 =
49 mm/Hg, HCO3 = 40 mEq/L. The patient has uncompensated metabolic alkalosis. The following set of blood
gases were found in a young man admitted to the ED wth Kussmaul breathing and an irregular pulse. pH = 7.32,
PaCO2 = 15 mm Hg, HCO3 = 6 mEq/L. This patient has uncompensated metabolic acidosis due to the very low
HCO3 level.
48. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
oncotic pressure
(ŏng-kŏt'ı̆k prĕsh'ŭr)
48. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
AThe patient with 60% second degree burns has damage to capillary ____________________
beds and decreased plasma proteins to maintain oncotic pressure. ____________________
____________________
____________________
49. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
osmosis
(ŏz-mō'sı̆s)
49. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
Administration of 0.45% sodium chloride (a hypotonic solution) will ____________________
move by osmosis from the plasma compartment into the interstitial and ____________________
cellular compartments.
____________________
____________________
50. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
osmolarity/osmolality
(ŏs''mō-lăr' ı̆-tē/ŏs''mō-lăl'ı̆-tē)
50. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The osmolarity of 5% dextrose ____________________________________________
in 0.45 % sodium chloride is ____________________________________________
406 mOsm.
____________________________________________
____________________________________________
51. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
pH
51. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
DE
AT
AT
DE
H
1 part of carbonic acid 20 parts of biocarbonate
H2CO3 1.20 mM/L HCO3- 24 mEq/L
APPLICATION: NOTES:
The blood gas results reflected a pH of 7.48, a alkalotic condition. ____________________
____________________
____________________
____________________
52. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The patient in postanesthesia ____________________________________________
recovery required Dextran 40 in ____________________________________________
0.9% sodium chloride as a
plasma volume expander due to ____________________________________________
blood loss in the operating room. ____________________________________________
53. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
replacement therapy
(rē-plās'mĕnt thĕr'ă-pē)
53. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The patient receiving chemother- ____________________________________________
apy required replacement ther- ____________________________________________
apy of platelets at the outpatient
infusion center due to a platelet ____________________________________________
count of 50,000. ____________________________________________
54. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
1. respiratory acidosis
(rĕs'-pı̆r ă-tōr''ē ăs''ı̆-dō'sı̆s)
2. respiratory alkalosis
(rĕs'-pı̆ră-tōr''ē ăl''kă-lō'sı̆s)
54. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
A patient is hypoventilating because of a respiratory depressant drug ____________________
overdose, with a pH below the normal range (<7.35); therefore this is ____________________
acidosis and the PaCO2 is 80, far above normal. This is uncompensated
respiratory acidosis. ____________________
____________________
55. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
Trousseau’s sign
(troo-sōz sı̄n)
55. FLUID, ELECTROLYTES, AND PARENTERAL SOLUTIONS
APPLICATION: NOTES:
The student nurse taking the postoperative thyroidectomy patient’s ____________________
vital signs noted a carpopedal attitude of the hand and fingers when the
____________________
blood pressure pump was inflated. She reported this to the instructor
who explained the need to report this Trousseau’s sign to the physician. ____________________
____________________
56. EQUIPMENT TERMS
cannula
(kăn' ū-lă)
56. EQUIPMENT TERMS
APPLICATION: NOTES:
The infusion nurse chose a #20 ____________________________________________
cannula to begin the infusion of ____________________________________________
5% dextrose and 0.45% sodium
chloride in the cephalic vein. ____________________________________________
____________________________________________
57. EQUIPMENT TERMS
check valve
(chĕk vălv)
57. EQUIPMENT TERMS
APPLICATION: NOTES:
The check valve stopped the back ____________________________________________
flow of the secondary infusion of ____________________________________________
gentamicin into the primary 5%
dextrose in 0.45% sodium ____________________________________________
chloride. ____________________________________________
58. EQUIPMENT TERMS
drip chamber
(drı̆p chām'bĕr)
58. EQUIPMENT TERMS
APPLICATION: NOTES:
The drip chamber had a micro- ____________________________________________
drip in the drop orifice deliver- ____________________________________________
ing 60 drops per milliliter.
____________________________________________
____________________________________________
59. EQUIPMENT TERMS
drop factor
(drŏp făk'tŏr)
59. EQUIPMENT TERMS
APPLICATION: NOTES:
The administration set package ____________________________________________
stated that the blood administra- ____________________________________________
tion set drop factor was 60 gtt/mL.
____________________________________________
____________________________________________
60. EQUIPMENT TERMS
elastomeric pump
(ē''lăs-tō'mĕr-ı̆k pŭmp)
60. EQUIPMENT TERMS
APPLICATION: NOTES:
The home-care nurse brought ____________________________________________
the 50-mL elastomeric pump ____________________________________________
to the client with instructions
for the family on delivery of the ____________________________________________
medication via the pump every ____________________________________________
6 hours.
61. EQUIPMENT TERMS
APPLICATION: NOTES:
The electronic infusion device ____________________________________________
was set for 100 milliliters per ____________________________________________
hour as a primary infusion.
____________________________________________
____________________________________________
62. EQUIPMENT TERMS
filter
(f ı̆l't ĕr)
62. EQUIPMENT TERMS
APPLICATION: NOTES:
A 0.22 micron filter is used to ____________________________________________
filter microbes and air from a ____________________________________________
primary administration set.
____________________________________________
____________________________________________
63. EQUIPMENT TERMS
gauge
(gāj)
63. EQUIPMENT TERMS
APPLICATION: NOTES:
The nurse starting an infusion ____________________________________________
used a #20 gauge 1 inch over- ____________________________________________
the-needle catheter placed in the
cephalic vein. ____________________________________________
____________________________________________
64. EQUIPMENT TERMS
hub
(hŭb)
64. EQUIPMENT TERMS
APPLICATION: NOTES:
The hub of the infusion device ____________________________________________
has threads to lock the syringe in ____________________________________________
place during a flush.
____________________________________________
____________________________________________
65. EQUIPMENT TERMS
infusate
(ı̆n-f ū'zāt)
65. EQUIPMENT TERMS
APPLICATION: NOTES:
The infusate of albumin was ____________________________________________
completed within 2 hours. ____________________________________________
____________________________________________
____________________________________________
66. EQUIPMENT TERMS
APPLICATION: NOTES:
The order from the physician ____________________________________________
stated to convert the continuous ____________________________________________
infusion of 0.9% sodium chloride
to an intermittent infusion using ____________________________________________
a locking device (or saline lock). ____________________________________________
67. EQUIPMENT TERMS
lumen
(lū'mĕn)
67. EQUIPMENT TERMS
APPLICATION: NOTES:
The dual-lumen peripherally ____________________________________________
inserted central catheter dress- ____________________________________________
ing was scheduled to be changed
24 hours after insertion. ____________________________________________
____________________________________________
68. EQUIPMENT TERMS
macrodrop
(măk'rō-drŏp'')
68. EQUIPMENT TERMS
APPLICATION: NOTES:
The outpatient surgicenter rou- ____________________________________________
tinely uses macrodrip adminis- ____________________________________________
tration sets as part of the
presurgery infusion set. ____________________________________________
____________________________________________
69. EQUIPMENT TERMS
microdrop
(mı̄'krō-dr ŏp'')
69. EQUIPMENT TERMS
APPLICATION: NOTES:
The ICU nurse added a micro- ____________________________________________
drip administration set to the ____________________________________________
solution of heparin in order to
titrate the delivery of the ____________________________________________
medication in small amounts. ____________________________________________
70. EQUIPMENT TERMS
multichannel pumps
(mŭl''tı̄-chăn'ĕl pŭmpz)
70. EQUIPMENT TERMS
APPLICATION: NOTES:
Multichannel pumps are used ____________________________________________
in critical care areas for delivery ____________________________________________
of multiple solutions and
medications. ____________________________________________
____________________________________________
71. EQUIPMENT TERMS
needleless systems
(nē'dĕl-lĕs sı̆s'tĕmz)
71. EQUIPMENT TERMS
APPLICATION: NOTES:
The infusion clinic converted to ____________________________________________
a new needleless system. ____________________________________________
____________________________________________
____________________________________________
72. EQUIPMENT TERMS
over-the-needle catheter
(ō'vĕr nē-dĕl kăth' ĕ-tĕr)
72. EQUIPMENT TERMS
APPLICATION: NOTES:
A # 20 gauge over-the-needle ____________________________________________
catheter was used to initiate the ____________________________________________
infusion on the adult waiting for
outpatient surgery. ____________________________________________
____________________________________________
73. EQUIPMENT TERMS
patient-controlled analgesia
(PCA)
(pā'shĕnt kŏn-trōl'ed ăn-ăl-jē'zē-ă)
73. EQUIPMENT TERMS
APPLICATION: NOTES:
The physician ordered morphine ____________________________________________
via patient-controlled analgesia ____________________________________________
postoperatively for the 62-year-
old client with hip resurfacing. ____________________________________________
____________________________________________
74. EQUIPMENT TERMS
injection port
(ı̆n-jĕk'shŭn pŏrt)
74. EQUIPMENT TERMS
APPLICATION: NOTES:
The injection port was cleaned ____________________________________________
with an alcohol swab using a ____________________________________________
twisting motion prior to delivery
of the IV medication. ____________________________________________
____________________________________________
75. EQUIPMENT TERMS
APPLICATION: NOTES:
The student nurse, gathering ____________________________________________
equipment for the initial intra- ____________________________________________
venous infusion, chose a primary
macrodrip administration set and ____________________________________________
the prescribed solution. ____________________________________________
76. EQUIPMENT TERMS
radiopaque
(rā-dē-ō-pāk')
76. EQUIPMENT TERMS
APPLICATION: NOTES:
The catheter embolized after in- ____________________________________________
sertion and was detected on radi- ____________________________________________
ographic examination because of
the radiopaque quality of the ____________________________________________
catheter. ____________________________________________
77. EQUIPMENT TERMS
APPLICATION: NOTES:
The student nurse chose the ____________________________________________
appropriate secondary adminis- ____________________________________________
tration set to administer the
piggyback medication. ____________________________________________
____________________________________________
78. EQUIPMENT TERMS
syringe pumps
(sı̆r-inj' pŭmpz)
78. EQUIPMENT TERMS
APPLICATION: NOTES:
The syringe pump technology ____________________________________________
was applied to patient-controlled ____________________________________________
analgesia pumps.
____________________________________________
____________________________________________
79. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
basilic vein
(bă-sı̆l' ı̆k vān)
79. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
___________________
___________________
80. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
cannulation
(kăn''ū-lā'shŭn)
80. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse can use the direct or ____________________________________________
indirect method of cannulation
technique for insertion of over-
____________________________________________
the-needle catheters. ____________________________________________
____________________________________________
81. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
cephalic vein
(sĕ-făl'ı̆k vān)
81. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
NOTES:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
82. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
chlorhexidine
(klor-hĕk'sı̆-dēn)
82. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
A skin prep for 20 seconds with ____________________________________________
Chlorhexidine (gluconate) should ____________________________________________
be used prior to insertion of the
peripheral catheter. ____________________________________________
____________________________________________
83. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
digital veins
(dı̆j'ı̆-tăl vānz)
83. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
Metacarpal
veins
Digital
NOTES: veins
____________________________________________
____________________________________________
____________________________________________
____________________________________________
84. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
distal
(dı̆s'tăl)
84. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The IV placed in the lower ____________________________________________
cephalic vein had infiltrated and ____________________________________________
the nurse was aware that she
could not initiate infusion ther- ____________________________________________
apy distal to that site. ____________________________________________
85. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
dermis
(dĕr'mı̆s)
85. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The epidermis and dermis of the ____________________________________________
80-year-old woman upon assess- ____________________________________________
ment were very thin; therefore,
the nurse had to use special ____________________________________________
techniques in initiating infusion ____________________________________________
therapy.
86. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
drop factor
(drŏp făk'tŏr)
86. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse in the rural clinic needed to set up an infusion to gravity us- ____________________
ing a primary administration set with a drop factor of 15 at a rate of ____________________
125 mL per hour. A formula was needed to set the drip rate.
____________________
Drop factor × mL/hour = drop per minute
60 (minutes)
____________________
87. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
endothelium
(ĕn''dō-thē'lē-ŭm)
87. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The intima of the vein is lined ____________________________________________
with endothelium and can be ____________________________________________
damaged with poor venipuncture
technique. ____________________________________________
____________________________________________
88. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
epidermis
(ĕp''ı̆-dĕr'mı̆s)
88. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse performed a 20-second ____________________________________________
prep with antimicrobial solution ____________________________________________
of the epidermis prior to insertion
of the catheter. ____________________________________________
____________________________________________
89. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
flushing
(flŭsh'ı̆ng)
89. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse prepared the morphine, 5 mg to be given IV push over ____________________
5 minutes, along with two prefilled flushing solutions—one for prior to ____________________
administration of the medication into the intermittent infusion device
and one for post administration. ____________________
____________________
90. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
metacarpal veins
(mĕt''ă-kăr'păl vānz)
90. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
NOTES:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
91. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
NOTES:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
These veins are often used for venipuncture for blood withdrawal and in emergency cases for access.
92. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
midline catheter
(mı̆d'lı̄n kăth'ĕ-tĕr)
92. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse inserted a midline ____________________________________________
catheter to support the infusion ____________________________________________
of the peripheral nutritional sup-
port over a period of 7 days. ____________________________________________
____________________________________________
93. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
palpation
(păl-pā'shŭn)
93. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse, prior to venipuncture, ____________________________________________
used palpation of the veins of the ____________________________________________
hand and lower arm to determine
which vein would be most appro- ____________________________________________
priate for infusion therapy. ____________________________________________
94. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
prime
(prı̄m)
94. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
NOTES:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
95. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
proximal
(prŏk'sı̆m-ăl)
95. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The IV site in the hand appeared
____________________________________________
reddened and the patient com-
plained of pain at the site. The ____________________________________________
nurse discontinued the infusion ____________________________________________
and catheter, and restarted the
infusion proximal to the previous ____________________________________________
infusion site.
96. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
skin receptors:
1. mechanoreceptors
(mĕk''ă-nō-rē-sĕp'torz)
2. thermoreceptors
(thĕr''mō-rē-sĕp'torz)
3. nociceptor
(nō''sē-sĕp'tor)
4. chemoreceptors
(kē''mō-rē-sĕp'torz)
96. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
Application of the physiology of ____________________________________________
nociceptors must be considered ____________________________________________
prior to venipuncture to decrease
the discomfort of initiation of ____________________________________________
infusion therapy. ____________________________________________
97. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
tangential lighting
(tăn-jĕn'shŭl lı̄t'ı̆ng)
97. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
Tangential lighting was used ____________________________________________
with a small flashlight to illumi- ____________________________________________
nate the veins of the lower arm
and, thus, assist with access of ____________________________________________
the vein. ____________________________________________
98. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
1. tunica adventitia
(tū'nı̆-kă ăd''vĕn-tı̆sh' ē-ă)
2. tunica media
(tū'nı̆-kă m̆ē'dē-ă)
3. tunica intima
(tū'nı̆-kă ı̆n'tı̆-mă)
98. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse must keep in mind ____________________________________________
that the intima of the vein is ____________________________________________
fragile and that good venipunc-
ture technique is important to ____________________________________________
prevent damage to this third ____________________________________________
layer of the vein.
99. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
transdermal analgesia
(trăns-dĕr'măl ăn-ăl-jē'zē-ă)
99. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
The nurse provided transdermal analgesia with EMLA cream covered ____________________
with occlusive dressing 30 minutes prior to venipuncture. ____________________
____________________
____________________
100. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
transparent semipermeable
membrane dressing (TSM)
(trăns-păr'ĕnt sĕm''ē-per'mē-ă-bl mĕm'brān drĕs-ı̆ng)
100. TECHNIQUES/MAINTENANCE PERIPHERAL IVS
APPLICATION: NOTES:
After the #20 over-the-needle ____________________________________________
catheter was stabilized, a TSM ____________________________________________
dressing was applied and labeled
with the time of venipuncture, ____________________________________________
date, size catheter, and nurse’s ____________________________________________
initials.
101. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The new bundles for prevention ____________________________________________
of catheter-related bloodstream ____________________________________________
infections include assessing the
client early for placement of a ____________________________________________
CVC. ____________________________________________
102. TECHNIQUES/MAINTENANCE CENTRAL IVS
external jugular
(ĕks-tĕr'năl jŭg' ū-lăr)
102. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
In an acute care setting, nurses ____________________________________________
who are proficient in infusion ____________________________________________
therapy may insert a peripheral
IV by accessing the external ____________________________________________
jugular. ____________________________________________
103. TECHNIQUES/MAINTENANCE CENTRAL IVS
flushing CVC
(flŭsh'ı̆ng)
103. TECHNIQUES/MAINTENANCE CENTRAL IVS
Groshong® valve
(Grō'shŏng vălv)
104. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
®
The Groshong valve feature is included in many types of central ____________________
lines—PICC, tunneled, and ports. ____________________
____________________
____________________
105. TECHNIQUES/MAINTENANCE CENTRAL IVS
Hickman catheter
(Hı̆k'măn kăth'ĕ-tĕr)
105. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The Hickman catheter was ____________________________________________
placed so the client could ____________________________________________
receive chemotherapy over the
next 8 months. ____________________________________________
____________________________________________
106. TECHNIQUES/MAINTENANCE CENTRAL IVS
implanted port
(ı̆m'plănt- ĕd pŏrt)
106. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The implanted port was accessed ____________________________________________
with a safety needle that uses a ____________________________________________
noncoring needle.
____________________________________________
____________________________________________
107. TECHNIQUES/MAINTENANCE CENTRAL IVS
infraclavicular
(ı̆n''fră-klă-vik'ū-lăr)
107. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The infraclavicular insertion site ____________________________________________
was inspected for redness and ____________________________________________
drainage per shift with docu-
mentation of visual inspection. ____________________________________________
____________________________________________
108. TECHNIQUES/MAINTENANCE CENTRAL IVS
ports (injection):
1. distal port
(dı̆s'tăl pŏrt)
2. medial port
(mē'dē-ăl pŏrt)
3. proximal port
(prŏk'sı̆m-ăl pŏrt)
108. TECHNIQUES/MAINTENANCE CENTRAL IVS
Proximal
lumen port
(18-gauge
NOTES: lumen)
APPLICATION: NOTES:
The IV team placed the PICC in the right cephalic vein and verified ____________________
confirmation of the tip in the superior vena cava prior to starting the ____________________
client on total parenteral nutrition.
____________________
____________________
110. TECHNIQUES/MAINTENANCE CENTRAL IVS
polyurethane
(pŏl''ē-yŭr'ĕ-thān)
110. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The polyurethane catheter was ____________________________________________
also coated with chlorhexidine/ ____________________________________________
silver sulfadiazine on the internal
and external luminal surfaces as a ____________________________________________
means of reducing catheter-related ____________________________________________
bloodstream infections (CRBSI).
111. TECHNIQUES/MAINTENANCE CENTRAL IVS
pulsatile flushing
(push-pause)
(pŭl'să-tı̆l flŭsh'ı̆ng) (poosh-păwz)
111. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The nurse administered the ____________________________________________
medication into the PICC and ____________________________________________
flushed the catheter with 5 mL
of preservative-free sodium chlo- ____________________________________________
ride in a 10-mL syringe using a ____________________________________________
push-pause technique.
112. TECHNIQUES/MAINTENANCE CENTRAL IVS
silicone elastomer
(sı̆l'ı̆-kōn ē''lăs-tō'mĕr)
112. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The peripherally inserted central ____________________________________________
catheter was made of silicone ____________________________________________
elastomer.
____________________________________________
____________________________________________
113. TECHNIQUES/MAINTENANCE CENTRAL IVS
APPLICATION: NOTES:
The hospital distributed a memo ____________________________________________
requesting that those nurses ____________________________________________
interested in being on the VAD
committee contact the infusion ____________________________________________
therapy department. ____________________________________________
114. COMPLICATIONS
air embolism
(ār ĕm'bō-lı̆zm)
115. COMPLICATIONS
APPLICATION: NOTES:
The nurse, following protocol ____________________________________________
for the central line dressing and ____________________________________________
administration cap change, had
the patient hold his breath while ____________________________________________
disconnecting the cap in order to ____________________________________________
prevent air embolism.
116. COMPLICATIONS
catheter malposition
(kăth'ĕ-tĕr măl-pō-zı̆'shŭn)
116. COMPLICATIONS
APPLICATION: NOTES:
The advanced practice infusion nurse read the x-ray to verify place- ____________________
ment and noted that the catheter was malpositioned in the right atrium. ____________________
The radiologist confirmed that the catheter needed to be repositioned.
____________________
____________________
117. COMPLICATIONS
APPLICATION: NOTES:
The nurse noted that the patient was short of breath with wet lung ____________________
sounds and increased peripheral edema; upon inspection of IV solu- ____________________
tion, she noted that 0.9% sodium chloride was infusing and the order
had read 0.45% sodium chloride. The nurse immediately slowed the ____________________
infusion and contacted the physician for new solution order to prevent ____________________
further circulatory overload.
118. COMPLICATIONS
extravasation
(ĕks-trăv''ă-sā'shŭn)
118. COMPLICATIONS
APPLICATION: NOTES:
The antidote for extravasation of ____________________________________________
dopamine is 5 to 10 mg phento- ____________________________________________
lamine mesylate by intradermal
administration. ____________________________________________
____________________________________________
119. COMPLICATIONS
fibrin sheath
(fı̄'brı̆n shēth)
119. COMPLICATIONS
graft-versus-host disease
(GVHD)
(grăft vĕr'sŭs hōst dı̆-zēz')
120. COMPLICATIONS
APPLICATION: NOTES:
The immunocompromised client ____________________________________________
was at risk for graft-versus-host ____________________________________________
disease.
____________________________________________
____________________________________________
121. COMPLICATIONS
hematoma
(hē''mă-tō'mă)
121. COMPLICATIONS
APPLICATION: NOTES:
The nurse inserted the #20 over- ____________________________________________
the-needle catheter into the vein ____________________________________________
of an elderly 80-year-old female
with the immediate formation of ____________________________________________
a hematoma. ____________________________________________
122. COMPLICATIONS
hemothorax
(hē''mō-thō'răks)
122. COMPLICATIONS
APPLICATION: NOTES:
The physician inserted the central ____________________________________________
line and upon x-ray verification of ____________________________________________
placement noted the patient had
developed a hemothorax. ____________________________________________
____________________________________________
123. COMPLICATIONS
hypothermia
(hı̄''pō-thĕr'mē-ă)
123. COMPLICATIONS
APPLICATION: NOTES:
The nurse in post-anesthesia ____________________________________________
recovery (PAR) set up the blood ____________________________________________
warmer in anticipation of infu-
sion of additional blood compo- ____________________________________________
nents to the trauma patient to ____________________________________________
prevent hypothermia.
124. COMPLICATIONS
infiltration
(ı̆n''fı̆l-trā'shŭn)
124. COMPLICATIONS
APPLICATION: NOTES:
Upon inspection of the IV site, ____________________________________________
the nurse noted edema and the ____________________________________________
site was cool to touch; the infil-
tration was rated at a grade 2. ____________________________________________
____________________________________________
125. COMPLICATIONS
local infection
(lō'kăl ı̆n-fĕk'shŭn)
125. COMPLICATIONS
APPLICATION: NOTES:
The catheter site was not rotated for more than 96 hours and it was noted ____________________
that there was purulent material under the transparent dressing. The ____________________
nurse cultured the site and catheter in anticipation of a local infection.
____________________
____________________
126. COMPLICATIONS
phlebitis
(flĕ-bı̄'tı̆s)
126. COMPLICATIONS
APPLICATION: NOTES:
Upon assessment of the infusion site, the patient complained of pain at ____________________
the access site, and it was noted that there was a red streak extending up ____________________
the vein and the nurse felt a palpable cord along the vein. The catheter
was discontinued and a 3+ phlebitis was reported to the physician. ____________________
____________________
127. COMPLICATIONS
pinch-off syndrome
(pı̆nch ŏff sı̆n'drōm)
127. COMPLICATIONS
APPLICATION: NOTES:
The nurse encountered difficulty in aspiration of blood and resistance ____________________
when the subclavian catheter was flushed, along with the patient com- ____________________
plaining of infraclavicular pain. The nurse suspected pinch-off
syndrome. ____________________
____________________
128. COMPLICATIONS
pneumothorax
(nū-mō-thō'răks)
128. COMPLICATIONS
APPLICATION: NOTES:
Upon insertion of the central line ____________________________________________
the patient complained of chest ____________________________________________
pain and dyspnea; a crunching
sound on auscultation was heard. ____________________________________________
X-ray confirmed a pneumothorax ____________________________________________
post central line insertion.
129. COMPLICATIONS
pulmonary edema
(pŭl'mō-nĕ-rē ĕ-dē'mă)
129. COMPLICATIONS
APPLICATION: NOTES:
The patient presented with signs ____________________________________________
of pulmonary edema including ____________________________________________
shortness of breath, 3+ pitting
edema of the extremities, and ____________________________________________
moist lung sounds. ____________________________________________
130. COMPLICATIONS
refeeding syndrome
(rē-fēd'ı̆ng sı̆n'drōm)
130. COMPLICATIONS
APPLICATION: NOTES:
Refeeding syndrome can be ____________________________________________
avoided by initiating TPN ____________________________________________
slowly, then gradually increasing
the rate while carefully monitor- ____________________________________________
ing the patient’s response and ____________________________________________
serum electrolyte levels.
131. COMPLICATIONS
septicemia
(sĕp-tı̆-sē'mē-ă)
131. COMPLICATIONS
APPLICATION: NOTES:
The patient was transferred from ____________________________________________
the medical-surgical unit to ____________________________________________
intensive care with septicemia,
unknown source. ____________________________________________
____________________________________________
132. COMPLICATIONS
speed shock
(spēd shŏk)
132. COMPLICATIONS
APPLICATION: NOTES:
The nurse drew up the meperidine ____________________________________________
and administered the medication ____________________________________________
rapidly through the patient’s injec-
tion port; the patient responded ____________________________________________
with syncope and shock symp- ____________________________________________
toms from the speed shock.
133. COMPLICATIONS
APPLICATION: NOTES:
The client with an implanted port upper chest was peppered with a ____________________
bluish venous star-shaped design; the nurse suspected superior vena ____________________
cava syndrome.
____________________
____________________
134. COMPLICATIONS
thrombosis
(thrŏm-bō'sı̆s)
134. COMPLICATIONS
APPLICATION: NOTES:
Thrombosis can develop within ____________________________________________
or around the catheter or in the ____________________________________________
surrounding vessel.
____________________________________________
____________________________________________
135. COMPLICATIONS
thrombophlebitis
(thrŏm''bō-flē-bı̄'tı̆s)
135. COMPLICATIONS
APPLICATION: NOTES:
The patient received 20 mg of potassium chloride via secondary infu- ____________________
sion over 3 hours; the nurse assessed the vein for thrombophlebitis for- ____________________
mation post infusion.
____________________
____________________
136. COMPLICATIONS
venospasm
(vē'nō-spăzm)
136. COMPLICATIONS
APPLICATION: NOTES:
The nurse began the transfusion ____________________________________________
and the patient almost immedi- ____________________________________________
ately complained of severe pain
at the infusion site. The nurse ____________________________________________
suspected venospasm. ____________________________________________
137. INFUSION MODALITIES
bolus
(bō'lŭs)
137. INFUSION MODALITIES
APPLICATION: NOTES:
The physician ordered a bolus of ____________________________________________
10 mEq of potassium chloride, ____________________________________________
which needed to be administered
over a minimum of 1 hour accord- ____________________________________________
ing to the drug reference and di- ____________________________________________
luted in 50 to 100 mL of infusate.
138. INFUSION MODALITIES
chemical incompatibility
(kĕm'ı̆k-ăl ı̆n''kŏm-păt-ı̆-bı̆l'ı̆-tē)
138. INFUSION MODALITIES
APPLICATION: NOTES:
The medication was reconstituted ____________________________________________
with the wrong solution resulting ____________________________________________
in a chemical incompatibility.
____________________________________________
____________________________________________
139. INFUSION MODALITIES
epidural
(ĕp''ı̆-dūr'ăl)
139. INFUSION MODALITIES
APPLICATION: NOTES:
The epidural route for adjunct ____________________________________________
pain management was started in ____________________________________________
the operating room for postopera-
tive patient pain control post ____________________________________________
pancreatic tumor resection. ____________________________________________
140. INFUSION MODALITIES
APPLICATION: NOTES:
Ceftazidime (Fortaz) 1 gram ____________________________________________
in 100 mL of 0.9% NaCl was ____________________________________________
administered by intermittent
drug infusion preoperatively. ____________________________________________
____________________________________________
141. INFUSION MODALITIES
intraperitoneal (IP)
(ı̆n''tră-pĕr''ı̆-tō-nē'ăl)
141. INFUSION MODALITIES
APPLICATION: NOTES:
The purpose of intraperitoneal therapy for the patient with ovarian can- ____________________
cer was to increase the concentration of an antineoplastic agent at the ____________________
tumor site and enhance its penetration and cell kill while limiting sys-
temic effects. ____________________
____________________
142. INFUSION MODALITIES
intraspinal
(ı̆n''tră-spı̄'năl)
142. INFUSION MODALITIES
APPLICATION: NOTES:
Intraspinal medication delivery ____________________________________________
via the epidural route can be ____________________________________________
used for acute, chronic, or can-
cer pain management. ____________________________________________
____________________________________________
143. INFUSION MODALITIES
intrathecal (IT)
(ı̆n''tră-thē'kăl)
143. INFUSION MODALITIES
APPLICATION: NOTES:
The anesthesiologist set up the ____________________________________________
intrathecal opioid infusion by ____________________________________________
implanted infusion pump for the
cancer patient to provide ade- ____________________________________________
quate pain relief. ____________________________________________
144. INFUSION MODALITIES
APPLICATION: NOTES:
The nurse administered the mor- ____________________________________________
phine sulfate 5 mg by IV push ____________________________________________
over 5 minutes.
____________________________________________
____________________________________________
145. INFUSION MODALITIES
physical incompatibility
(fı̆z'ı̆-kăl ı̆n''kŏm-pă''tı̆-bı̆l'ı̆-tē)
145. INFUSION MODALITIES
APPLICATION: NOTES:
Calcium in a drug or solution ____________________________________________
may cause physical incompatibility ____________________________________________
with some added medications.
____________________________________________
____________________________________________
146. INFUSION MODALITIES
therapeutic incompatibility
(thĕr-ă-pū'tı̆k ı̆n''kŏm-pă''tı̆-bı̆l'ı̆-tē)
146. INFUSION MODALITIES
APPLICATION: NOTES:
The peak blood level drawn for chloramphenicol did not show a thera- ____________________
peutic response. Due to the administration of an additional antibiotic, ____________________
the physician concluded there was therapeutic incompatibility between
the two drugs and one was discontinued. ____________________
____________________
147. TRANSFUSION THERAPY
ABO system
(ā-bē-ō sı̆s'tĕm)
147. TRANSFUSION THERAPY
APPLICATION: NOTES:
The patient was typed and cross- ____________________________________________
matched for ABO and Rh type. ____________________________________________
____________________________________________
____________________________________________
148. TRANSFUSION THERAPY
agglutinin
(ă-gloo'tı̆-nı̆n)
148. TRANSFUSION THERAPY
APPLICATION: NOTES:
In the test tube, the laboratory ____________________________________________
technician mixed blood to cross- ____________________________________________
match and assess for any agglu-
tinin formation. ____________________________________________
____________________________________________
149. TRANSFUSION THERAPY
agglutinogen
(ă-gloo-tı̆n'ō-jĕn)
149. TRANSFUSION THERAPY
APPLICATION: NOTES:
The ABO system is the most ____________________________________________
important agglutinogen located ____________________________________________
on the red blood cell (RBC)
membranes. ____________________________________________
____________________________________________
150. TRANSFUSION THERAPY
antibody
(ăn'tı̆-bŏd''ē)
150. TRANSFUSION THERAPY
APPLICATION: NOTES:
Antibodies, also called agglu- ____________________________________________
tinins, within the blood system ____________________________________________
are proteins that react with an
antigen. ____________________________________________
____________________________________________
151. TRANSFUSION THERAPY
antigen
(ăn'tı̆-jĕn)
151. TRANSFUSION THERAPY
APPLICATION: NOTES:
Antigens, also called agglutino- ____________________________________________
gens, are located on the RBC ____________________________________________
membranes.
____________________________________________
____________________________________________
152. TRANSFUSION THERAPY
autologous donor
(aw-tŏl'ō-gŭs dō'nŏr)
152. TRANSFUSION THERAPY
APPLICATION: NOTES:
The patient called the blood ____________________________________________
bank to set up an appointment ____________________________________________
for autologous donation of a unit
of blood 1 month prior to sched- ____________________________________________
uled surgery. ____________________________________________
153. TRANSFUSION THERAPY
designated donor
(dĕ'zı̆g-nāt'ĕd dō'nŏr)
153. TRANSFUSION THERAPY
APPLICATION: NOTES:
The 6-year-old boy received a unit of blood donated by his father, who ____________________
was blood type identical; the unit was designated to the specific child ____________________
after surgery.
____________________
____________________
154. TRANSFUSION THERAPY
APPLICATION: NOTES:
The fresh frozen plasma was ____________________________________________
thawed and transfused into the ____________________________________________
patient with dilutional coagu-
lopathy within 6 hours. ____________________________________________
____________________________________________
155. TRANSFUSION THERAPY
homologous donor
(hō-mŏl'ō-gŭs dō'nŏr)
155. TRANSFUSION THERAPY
APPLICATION: NOTES:
The blood drive on campus was ____________________________________________
to increase the pool of homolo- ____________________________________________
gous donors.
____________________________________________
____________________________________________
156. TRANSFUSION THERAPY
APPLICATION: NOTES:
HLA matching and leukocyte de- ____________________________________________
pletion of the donor unit help to ____________________________________________
decrease HLA alloimmunization.
____________________________________________
____________________________________________
157. TRANSFUSION THERAPY
APPLICATION: NOTES:
The patient was typed and cross- ____________________________________________
matched for 4 units of packed ____________________________________________
red blood cells.
____________________________________________
____________________________________________
158. TRANSFUSION THERAPY
platelets
(plāt'lĕtz)
158. TRANSFUSION THERAPY
APPLICATION: NOTES:
The patient received a single ____________________________________________
pheresis unit of random donor ____________________________________________
platelets.
____________________________________________
____________________________________________
159. TRANSFUSION THERAPY
Rh factor
(Rh făk'tŏr)
159. TRANSFUSION THERAPY
APPLICATION: NOTES:
A pregnant woman who has an ____________________________________________
Rh factor of Rh– delivered a Rh+ ____________________________________________
fetus, therefore she received
RhoGAM to prevent Rh antibody ____________________________________________
production after delivery. ____________________________________________
160. TRANSFUSION THERAPY
whole blood
(hōl blŭd)
160. TRANSFUSION THERAPY
APPLICATION: NOTES:
The patient with massive blood ____________________________________________
loss from a crushing injury to his ____________________________________________
lower body received type O neg-
ative whole blood initially upon ____________________________________________
admission to the ED. ____________________________________________
161. NUTRITIONAL SUPPORT
cyclic therapy
(sı̄'klı̆k thĕr'ă-pē)
161. NUTRITIONAL SUPPORT
APPLICATION: NOTES:
The quality of life for the ____________________________________________
teenager who needed total par- ____________________________________________
enteral nutrition was achieved
by use of cyclic therapy. ____________________________________________
____________________________________________
162. NUTRITIONAL SUPPORT
fat emulsion
(făt ē-mŭl'shŭn)
162. NUTRITIONAL SUPPORT
APPLICATION: NOTES:
The 500-mL glass container of ____________________________________________
fat emulsion (lipids) was admin- ____________________________________________
istered over 12 hours by second-
ary infusion on a daily basis. ____________________________________________
____________________________________________
163. NUTRITIONAL SUPPORT
peripheral parenteral
nutrition (PPN)
(pĕr-ı̆f'ĕr-ăl păr-ĕn'tĕr-ăl nū-trı̆'shŭn)
163. NUTRITIONAL SUPPORT
APPLICATION: NOTES:
The home care client was placed ____________________________________________
on 7 days of peripheral par- ____________________________________________
enteral nutrition while awaiting
bowel resection. ____________________________________________
____________________________________________
164. NUTRITIONAL SUPPORT
APPLICATION: NOTES:
The client with 30% burns over ____________________________________________
the head and chest area was ____________________________________________
placed on total parenteral nutri-
tion by central line to maintain ____________________________________________
calories for healing. ____________________________________________
165. NUTRITIONAL SUPPORT
APPLICATION: NOTES:
The home care client re- ____________________________________________
ceived total nutrient admix- ____________________________________________
ture with careful monitoring
for bloodstream infections. ____________________________________________
____________________________________________
166. IV THERAPY BONUS CARD PHILLIPS 15 STEPS
PRECANNULATION
Step 1: Obtain authorized prescriber’s order or Things to know—Assessment
review standardized procedure Patient’s medical diagnosis
History of chronic disease
Step 2: Hand hygiene–15 to 20 seconds History of vasovagal reaction during venipuncture
Alcohol-based hand rub
Previous experiences with vascular access
If hand visibly dirty or contaminated, use soap,
devices
water, and vigorous scrub
Cultural considerations
Step 3: Gather equipment and preparation Assess both arms and hands prior to choosing
Check integrity of solution appropriate vein
Check integrity of administration set Choose the lowest best vein
Gather venipuncture and dressing supplies Identify allergies
Step 4: Patient assessment, psychological Step 5: Apply tourniquet, site selection, and
preparation and patient identification vein dilation
Provide privacy Factors to consider:
Evaluate the patient’s preparedness for Patient receiving anticoagulation therapy
IV procedure Presence of disease or previous surgery
Check patient identification, using two (poor venous return)
identifers Presence of shunt for dialysis
166. IV THERAPY BONUS CARD PHILLIPS 15 STEPS
CANNULATION
Step 6: Needle selection Step 9: Vein entry: Direct or indirect
16 gauge: Trauma Direct: One-step method
18–20 gauge: Infusion of hypertonic or isotonic Indirect: Two-step method
solutions, or blood products
22–24 gauge: Pediatric patients Step 10: Catheter stabilization and dressing
22 gauge: Fragile veins in elderly management
Catheter should be stabilized in a manner
Step 7: Gloving that does not interfere with visualization
Standard precaution requires gloves to be worn of site
during placement of an IV catheter Dressing: Transparent semipermeable mem-
brane dressing (TSM)
Step 8: Site preparation
Use stabilization device that is recommended
Recommended to use 2% chlorhexidine
by INS and CDC
gluconate; use 15–20 second scrub with friction;
allow to dry
167. IV THERAPY BONUS CARD PHILLIPS 15 STEPS
POSTCANNULATION
Step 11: Labeling of site, and administration set Step 13: Patient education
Insertion site: Venipuncture site should be Patient must receive information on all aspects
labeled with of their care
Date and time Inform regarding any limitations of movement
Type and length of catheter or mobility
Nurse’s initials Explain all alarms if EID is used
Administration set Instruct to call for assistance
Label according to agency policy: Date on
which administration set must be changed Step 14: Rate calculation
Solution container See Rate Calculation Bonus Card 167.
Place a time strip on parenteral solutions Step 15: Monitoring and documentation
Any additive must have a clear label applied Document all aspects of procedure
to bag Document routine assessments of site every
Step 12: Equipment disposal 4 hours
Standard of practice: Needles and stylets shall Follow flush protocol if intermittent locking
be disposed of in nonpermeable device in place
tamper-proof containers Change IV site along with administration set
Dispose of all paper and plastic equipment in every 72 hours
biohazard container IV solutions may only hang 24 hours
167. IV THERAPY BONUS CARD RATE CALCULATION
COMMON DROP FACTORS
10 gtt = 1 mL
15 gtt = 1 mL
20 gtt = 1 mL } Macrodrops
60 mcgtt = 1 mL } Microdrops
3. To calculate drops/minute microdrop infusion
(note: EIDs are microdrip mL/hour versus gtt/min
hourly volume × 60 mcgtt tubing
= mL/hour
60 (time in minutes)
INFILTRATION SCALE
1. Subclavian vein
(Infusion of other solutions)
Median basilic
vein Axillary vein
Median cephalic Cephalic vein Internal jugular vein
vein
Brachiocephalic vein
Basilic vein
Illustrations that appear on cards 28, 37, 51, 94, 108, and
170 from Phillips, L.D. (2005). Manual of IV Therapeutics
(4th ed.). Philadelphia: F.A. Davis; cards 79, 81, 83, 90,
and 91: Courtesy and © Becton, Dickinson and Company;
card 169 courtesy of Medivisuals, Dallas, TX and courtesy
of BARD Access Systems. Tables on cards 168 and 169
with permission from the Infusion Nursing Society.